Company news

Evotec SE news in 2026

Evotec SE's news releases, calls and decks from 2026, newest first.

View company

Evotec SE to Announce Results for the First Nine Months 2026 on November 5, 2026

October 29, 2026

Ad hoc: Evotec announces preliminary nine-months 2026 results above market expectations, reaffirming full-year 2026 guidance

October 13, 2026

Evotec Announces Chief Scientific Officer Transition

September 29, 2026

Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors

September 2, 2026

Half-year report 2026, PDF (H1 Report 2026 English)

August 13, 2026

Half-year report 2026, PDF (Interim Statement H1 2026 English)

August 13, 2026

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

August 6, 2026

Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook

July 13, 2026

Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics

June 30, 2026

Presence and Voting Results AGM 2026 68.764 KB (EVT Abstimmung Liste EN)

June 12, 2026

Evotec Reports Results of the Annual General Meeting 2026

June 11, 2026

Evotec Appoints Rui Wang as Head of Global In Silico and AI

June 2, 2026

Letter of the Chair of Supervisory Board to the Shareholders of Evotec 116,952 KB

May 26, 2026

Evotec SE: Dr. Cord Dohrmann, sell

May 22, 2026

Evotec SE Successfully Placed €116.1 Million Convertible Bonds

May 12, 2026

Evotec SE launches approximately EUR 125 million convertible bond offering

May 12, 2026

Evotec Announces First Quarter 2026 Results: Building Transformation Momentum

May 6, 2026

Evotec SE: Paul Hitchin, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system.

May 5, 2026

Evotec SE: Aurélie Dalbiez, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system.

May 5, 2026

Evotec SE: Dr. Christian Wojczewski, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system.

May 5, 2026

Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall

May 4, 2026

Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access

January 8, 2026

Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations

January 2, 2026

Calls in 2026

Decks in 2026